Hippocratic AI
Founded Year
2023Stage
Series B | AliveTotal Raised
$276MValuation
$0000Last Raised
$141M | 3 mos agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
+52 points in the past 30 days
About Hippocratic AI
Hippocratic AI specializes in developing safety-focused generative artificial intelligence for the healthcare sector. The company offers a large language model that is designed to assist healthcare professionals by providing information and support without making diagnoses. Hippocratic AI's services are primarily utilized within the healthcare industry, healthcare access, and responsible AI deployment. It was founded in 2023 and is based in Palo Alto, California.
Loading...
ESPs containing Hippocratic AI
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The healthcare AI model developers market creates specialized AI models for clinical and administrative applications in healthcare settings. These include foundational models and large language models designed specifically for healthcare use cases such as revenue cycle management, medical imaging, and clinical insights generation. Companies in this market leverage their respective AI models to add…
Hippocratic AI named as Leader among 14 other companies, including Google, Microsoft, and NVIDIA.
Loading...
Research containing Hippocratic AI
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Hippocratic AI in 10 CB Insights research briefs, most recently on Mar 11, 2025.
Mar 6, 2025
The AI agent market map
Dec 3, 2024 report
Digital Health 50: The most promising digital health startups of 2024
May 24, 2024
The generative AI market map
Expert Collections containing Hippocratic AI
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Hippocratic AI is included in 7 Expert Collections, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
1,270 items
Digital Health
11,306 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Generative AI 50
50 items
CB Insights' list of the 50 most promising private generative AI companies across the globe.
Generative AI
1,299 items
Companies working on generative AI applications and infrastructure.
Digital Health 50
100 items
Artificial Intelligence
7,221 items
Latest Hippocratic AI News
Apr 7, 2025
Search jobs 07-Apr-2025 Agentic AI in Healthcare Market Size, Trends and Growth Report: Increasing Demand from Healthcare & Pharma Sectors The global agentic AI in healthcare market is set to witness a growth rate of 35-40% in the next 5 years. Increasing demand for personalized healthcare solutions; rapid advances in AI technology; healthcare industry’s growing shift toward preventive care; and integration of AI in diagnostics are some of the key factors driving the agentic AI in healthcare market. Agentic AI in healthcare refers to autonomous artificial intelligence systems capable of making independent decisions and performing tasks without requiring human intervention. These systems are designed to analyze complex medical data, predict outcomes, and provide recommendations or actions in real-time. Unlike traditional AI, agentic AI goes beyond providing insights to executing decisions, such as optimizing treatment plans, managing resources, or conducting precision diagnostics. Its applications span personalized medicine, diagnostics, drug discovery , and remote patient management. By leveraging advanced algorithms and machine learning, agentic AI aims to enhance efficiency, accuracy, and accessibility in healthcare, addressing workforce shortages and improving patient outcomes. Explore market trends, size, share and growth report - request a sample copy: https://meditechinsights.com/agentic-ai-in-healthcare-market/request-sample/ Increasing demand for personalized healthcare solutions to propel market demand The increasing demand for personalized healthcare solutions is a key driver for the Agentic AI in healthcare market. Personalized care requires tailored treatment plans based on an individual’s genetic, environmental, and lifestyle factors. Agentic AI, with its autonomous decision-making capabilities, processes vast datasets to identify unique patient needs, predict disease risks, and recommend precise therapies. This technology enables healthcare providers to move beyond one-size-fits-all approaches, improving treatment outcomes and patient satisfaction. As chronic diseases and genetic research grow, the ability of Agentic AI to deliver real-time, patient-specific insights is fueling its adoption across healthcare systems globally. Rapid advances in AI technology are driving the market growth Rapid advances in AI technology are significantly driving the growth of the Agentic AI in healthcare market. Innovations in machine learning algorithms, natural language processing, and deep learning enable these systems to process and analyze complex medical data with unprecedented accuracy and speed. Enhanced computational power and access to big data are further empowering Agentic AI to provide real-time decision-making and predictive insights in healthcare. These technological advancements facilitate applications like precision diagnostics, personalized medicine, and automated workflows, improving efficiency and patient outcomes. As AI capabilities continue to evolve, their integration into healthcare systems accelerates market expansion. Competitive Landscape Analysis The global agentic AI in healthcare market is marked by the presence of established and emerging market players such as Microsoft Corporation; NVIDIA Corporation; Amazon Web Services, Inc.; IBM Corporation; Google DeepMind; GE HealthCare; OpenAI; Hippocratic AI Inc.; Automation Anywhere, Inc.; Genie AI Ltd.; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion. Explore the latest trends and deep competitive insights in just one click: https://meditechinsights.com/agentic-ai-in-healthcare-market/ Global Agentic AI in Healthcare Market Segmentation This report by Medi-Tech Insights provides the size of the global agentic AI in healthcare market at the regional- and country-level from 2023 to 2030. The report further segments the market based on Offering, application, and, end user. Market Size & Forecast (2023-2030), By Offering, USD Million Software Patient Monitoring Others Healthcare Providers North America
Hippocratic AI Frequently Asked Questions (FAQ)
When was Hippocratic AI founded?
Hippocratic AI was founded in 2023.
Where is Hippocratic AI's headquarters?
Hippocratic AI's headquarters is located at 167 Hamilton Avenue, Palo Alto.
What is Hippocratic AI's latest funding round?
Hippocratic AI's latest funding round is Series B.
How much did Hippocratic AI raise?
Hippocratic AI raised a total of $276M.
Who are the investors of Hippocratic AI?
Investors of Hippocratic AI include General Catalyst, Andreessen Horowitz, Premji Invest, Universal Health Services, WellSpan Health and 12 more.
Who are Hippocratic AI's competitors?
Competitors of Hippocratic AI include mpathic and 7 more.
Loading...
Compare Hippocratic AI to Competitors
Hyro specializes in adaptive communications solutions utilizing artificial intelligence (AI) and computational linguistics technology. The company offers a full-stack conversational AI solution that automates repetitive tasks across various mediums and channels, including call center automation and conversational intelligence. It primarily serves the healthcare sector, providing solutions to improve patient engagement and overcome staffing shortages. Hyro was formerly known as Airbud. It was founded in 2018 and is based in New York, New York.
Syllable specializes in healthcare workflow automation. It focuses on enhancing patient satisfaction and reducing call center workloads through AI-powered solutions. The company offers a unified phone experience that leverages HIPAA-compliant AI to automate routine tasks such as appointment management and prescription refills, thereby improving patient access to care. Syllable's patient assistant console provides healthcare providers with comprehensive analytics and insights to manage and optimize patient interactions. It was founded in 2016 and is based in Mountain View, California.
AlayaCare focuses on providing cloud-based software solutions in the home health-care sector. The company offers solutions that include clinical documentation, back office functionality, client and family portals, and mobile care worker functionality, all designed to streamline home-based care agencies and health outcomes. AlayaCare primarily serves home care agencies, home health agencies, infusion operations, and hospice and palliative care providers. It was founded in 2014 and is based in Montreal, Canada.
Virtue Health specializes in digital therapeutics within the healthcare sector and focuses on the development of innovative approaches to treat age-related conditions. The company offers products that leverage science, technology, and design to treat and prevent long-term health conditions, aiming to improve the quality of life for an aging population. Virtue Health's solutions cater to various aspects of elderly care, including menopause management, dementia therapy, and chronic pain management for palliative care patients. Virtue Health was formerly known as VRTU. It was founded in 2017 and is based in London, United Kingdom.
Behavioral Signals operates in Emotion Cognitive AI within the artificial intelligence sector. The company provides technology that analyzes human behavior through voice data to facilitate communication and customer experiences in various industries. Its services include AI-mediated conversations, emotion recognition, and behavioral signal processing for call centers, sales, and defense applications. It was founded in 2016 and is based in Los Angeles, California.
Medable specializes in providing digital clinical trial software solutions within the healthcare and pharmaceutical sectors. The company offers a comprehensive platform that facilitates the management of clinical trials, including tools for remote data collection, electronic consent (eConsent), patient-reported outcomes (ePRO), and clinical outcome assessments (eCOA), all designed to streamline the trial process and enhance data quality. Medable was formerly known as Dermatrap. It was founded in 2012 and is based in Palo Alto, California.
Loading...